Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase
Clinical trial NCT00451035 · TERMINATED
Trial details
- NCT number
- NCT00451035
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-19
- Primary completion
- 2008-04-13
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.